Retrospective 199 sarcoidosis patients showing non-statistically significant HCQ RR 0.83, p
Desbois et al., 7/20/2020, retrospective, France, Europe, preprint, mean age 58.8, 13 authors.
risk of COVID-19 case, 16.9% lower, RR 0.83, p = 1.00, treatment 3 of 27 (11.1%), control 23 of 172 (13.4%).
Effect extraction follows pre-specified rules prioritizing more serious
outcomes. For an individual study the most serious outcome may have a smaller
number of events and lower statistical signficance, however this provides the
strongest evidence for the most serious outcomes when combining the results of